Evofem Biosciences, Inc. SEC filings EVFM
Evofem Biosciences, Inc. has 802 filings in SEC EDGAR's recent list, going back to Sep 12, 2014. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Aug 14, 2023 | — |
| S-1/A | Amended registration statement | Aug 11, 2023 | — |
| S-1/A | Amended registration statement | Aug 3, 2023 | — |
| S-1 | Registration statement | Jul 10, 2023 | — |
| 424B3 | Prospectus | Sep 30, 2022 | — |
| S-1 | Registration statement | Sep 23, 2022 | — |
| 424B5 | Prospectus supplement | May 23, 2022 | — |
| 424B5 | Prospectus supplement | May 20, 2022 | — |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| 424B5 | Prospectus supplement | Mar 1, 2022 | — |
| 424B5 | Prospectus supplement | Feb 16, 2022 | — |
| 424B5 | Prospectus supplement | Jan 13, 2022 | — |
| 424B5 | Prospectus supplement | Oct 12, 2021 | — |
| S-3 | Shelf registration | Jul 30, 2021 | — |
| 424B5 | Prospectus supplement | May 19, 2021 | — |
| 424B5 | Prospectus supplement | May 17, 2021 | — |
| 424B5 | Prospectus supplement | Mar 25, 2021 | — |
| 424B5 | Prospectus supplement | Mar 24, 2021 | — |
| S-3 | Shelf registration | Mar 4, 2021 | — |
| S-8 | Employee stock plan registration | Jan 28, 2021 | — |
| 424B5 | Prospectus supplement | Jun 3, 2020 | — |
| 424B5 | Prospectus supplement | Jun 2, 2020 | — |
| 424B3 | Prospectus | May 18, 2020 | — |
| 424B3 | Prospectus | May 18, 2020 | — |
| S-8 | Employee stock plan registration | May 13, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| S-3 | Shelf registration | Nov 18, 2019 | — |
| 424B3 | Prospectus | Jul 2, 2019 | — |
| S-3 | Shelf registration | Jun 24, 2019 | — |
| S-8 | Employee stock plan registration | Jun 6, 2019 | — |
| S-8 | Employee stock plan registration | Jun 6, 2019 | — |
| 424B3 | Prospectus | May 7, 2019 | — |
| S-3 | Shelf registration | Apr 30, 2019 | — |
| S-3 | Shelf registration | Mar 11, 2019 | — |
| S-8 | Employee stock plan registration | Aug 2, 2018 | — |
| S-8 | Employee stock plan registration | Jun 1, 2018 | — |
| 424B4 | Prospectus | May 22, 2018 | — |
| S-1 | Registration statement | May 16, 2018 | — |
| FWP | Free writing prospectus | May 9, 2018 | — |
| FWP | Free writing prospectus | May 9, 2018 | — |
| S-1/A | Amended registration statement | May 1, 2018 | — |
| S-1/A | Amended registration statement | Apr 24, 2018 | — |
| S-1 | Registration statement | Apr 6, 2018 | — |
| S-3/A | Filing | Mar 27, 2018 | — |
| S-3 | Shelf registration | Mar 16, 2018 | — |
| 424B3 | Prospectus | Dec 12, 2017 | — |
| S-4/A | Filing | Dec 7, 2017 | — |
| S-4 | Registration for a merger or exchange | Nov 15, 2017 | — |
| S-3 | Shelf registration | Dec 1, 2015 | — |
| S-8 | Employee stock plan registration | Mar 27, 2015 | — |
| S-8 | Employee stock plan registration | Nov 20, 2014 | — |
| 424B4 | Prospectus | Nov 20, 2014 | — |
| S-1MEF | Filing | Nov 19, 2014 | — |
| S-1/A | Amended registration statement | Nov 10, 2014 | — |
| S-1 | Registration statement | Oct 17, 2014 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EVFM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1618835
- Former names
- Neothetics, Inc. (until Jan 5, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.